drugset / Trial / NCT00320294
ILF With/Without Cisplatin for Advanced Gastric Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the combination of irinotecan, leucovorin and 5-FU (ILF) with ILF plus cisplatin (PILF) as first-line chemotherapy in patients with measurable metastatic gastric cancer.
Timeline
- Start
- 2005-02
- Primary completion
- —
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 30 mg/m2 | — |
| Background | Irinotecan | Small molecule | 150 mg/m2 | — |